New answer by Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center (December 20, 2021)
No great answers, unfortunately. Lenalidomide still tends to make me a bit nervous in AL amyloidosis, as does carfilzomib in patients with known cardiac involvement. But pom-b...